Scanning electromicrograph of an HIV-infected T cell. Photo: NIAID

A new drug to treat HIV just got approved in the U.S. — and it could shake up a US$22 billion market

The treatment uses two drugs instead of three or more, which has been the standard

Topic |   Medicine

TOP PICKS

Scanning electromicrograph of an HIV-infected T cell. Photo: NIAID
READ FULL ARTICLE